CA
VIRX

Clearstead Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Clearstead Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$10 – 1443
2022
Q4 		$10 Buy
+7
New +$10 ﹤0.01% 1304